Ozempic is the name-brand version of weekly injectable semaglutide that is FDA-approved for diabetes treatment, while Wegovy is the same injectable approved for obesity treatment
CrossRef Cholinesterase and the association between hepatic steatosis and liver fibrosis in patients with prior hepatitis E Ziteng Wang, Zhe Yu, Wen An, Herui Wei, Jing Luo, Mengqi Li, Lingling He, Jiali Ma, Fan Xiao, Lijuan Sun, Qi Gao, Hui Zhong, Hongshan Wei European Journal of Medical Research .2026;[Epub] CrossRef GLP-1RA plus SGLT2i combination therapy and liver fibrosis progression in MASLD with type 2 diabetes Jonggi Choi, Gabby Mitchell, Vy H
One of the innovative options we provide is semaglutide GLP-1, a medication originally developed to help manage type 2 diabetes but now widely used for weight management in adults living with obesity or overweight
Some people experience side effects like nausea and diarrhea within the first day or two after each dose